Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-020873
Filing Date
2024-02-13
Accepted
2024-02-13 17:04:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tv0873-esperiontherapeuticsi.htm SC 13G/A 11479
  Complete submission text file 0001104659-24-020873.txt   13141
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

EIN.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87536 | Film No.: 24628319
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)